Article info
Review
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
- Correspondence to Dr Barry J A Laird, University of Edinburgh, Edinburgh EH8 9YL, UK; barry.laird{at}ed.ac.uk
Citation
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
Publication history
- Received October 4, 2017
- Revision received November 16, 2017
- Accepted December 13, 2017
- First published February 9, 2018.
Online issue publication
August 10, 2020
Article Versions
- Previous version (16 August 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.